Onconetix | 4: Statement of changes in beneficial ownership of securities-Director Tarsh Simon
Onconetix | 4: Statement of changes in beneficial ownership of securities-Director SINGH AJIT
Onconetix | 4: Statement of changes in beneficial ownership of securities-Director SAPIRSTEIN JAMES
Onconetix | 4: Statement of changes in beneficial ownership of securities-Director Ramdeen Timothy R.
Onconetix | 4: Statement of changes in beneficial ownership of securities-Director Meier Thomas
Onconetix | SCHEDULE 13G: Others
Onconetix | 3: Initial statement of beneficial ownership of securities-10% Owner Altos Venture AG
Onconetix | SC 13D: Statement of acquisition of beneficial ownership by individuals-Altos Venture AG(32.5%)
Onconetix | 4: Statement of changes in beneficial ownership of securities-Officer Schiess Ralph
Onconetix | 4: Statement of changes in beneficial ownership of securities-Officer Bruhlmann Christian
Onconetix | SC 13G: Statement of acquisition of beneficial ownership by individuals-New Horizon Health Limited(6.91%)
Onconetix | 8-K: Current report
Onconetix | 8-K: Current report
Onconetix | 8-K: Current report
Onconetix | 8-K: Current report
Onconetix | 8-K: Current report
Onconetix | DEFA14A: Others
Onconetix | 8-K: Current report
Onconetix | 10-Q: Q2 2024 Earnings Report
Onconetix | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
No Data
No Data